Prognos Health, a NYC-based real-world integrated data marketplace for the healthcare industry, raised $23m in growth equity funding.
The round was co-led by Marshall Wace and Safeguard Scientifics, with participation from Cigna Ventures, Hikma Ventures, Hunt Holdings, Labcorp, Maywic, Merck Global Health Innovation Fund, and Red and Blue Ventures.
The company intends to use the funds to accelerate growth and expand the reach of its platform.
Led by Sundeep Bhan, CEO, Prognos Health is a real-world data (RWD) company that provides a managed RWD marketplace, accelerating the development and delivery of innovative therapies and improving health outcomes by offering fully integrated and harmonized lab and health records on more than 325 million de-identified patients. The solution provides a comprehensive and integrated view of patient health, enabling researchers, payers, and providers to make better decisions about care.
The platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.
Prognos Health’s real-world data marketplace has already made a significant impact in the . With this new funding, the company is poised to further accelerate the transformation of healthcare through the power of data.
FinSMEs
18/05/2023